ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,143Medicare Part D Prescriptions Filled, Including Refills

Rank: 801 out of 4623

$429K Total Retail Price of All Prescriptions

Rank: 972 out of 4623

400 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

16% of this provider’s 400 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 5,956 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LISINOPRIL 566 428 1 4
SIMVASTATIN 490 386 2 2
AMLODIPINE BESYLATE 346 291 3 5
METFORMIN HCL 324 246 4 6
HYDROCODONE-ACETAMINOPHEN 276 156 S3 5 3
LEVOTHYROXINE SODIUM 217 195 6 1
LOSARTAN POTASSIUM 194 173 7 21
ALLOPURINOL 185 158 8 37
METOPROLOL SUCCINATE 139 128 9 13
OMEPRAZOLE 139 89 9 7
GUANFACINE HCL 136 70 R 11 291
TRAZODONE HCL 122 88 12 42
TRAMADOL HCL 115 71 13 15
ATORVASTATIN CALCIUM 114 95 14 12
HYDROCHLOROTHIAZIDE 105 92 15 10
FLUTICASONE PROPIONATE 99 60 16 32
METOPROLOL TARTRATE 98 75 17 9
BUMETANIDE 96 85 18 211
AZITHROMYCIN 90 67 19 33
DONEPEZIL HCL 87 85 20 30
ZOLPIDEM TARTRATE 85 46 21 18
NEXIUM 84 60 22 17
PRAVASTATIN SODIUM 76 70 23 11
TAMSULOSIN HCL 73 69 24 29
AMLODIPINE BESYLATE-BENAZEPRIL 67 64 25 55
LOVASTATIN 66 48 26 34
ADVAIR DISKUS 63 49 27 62
CRESTOR 61 39 28 20
PANTOPRAZOLE SODIUM 59 54 29 35
ATENOLOL 58 58 30 28
LOVAZA 56 21 31 112
ALENDRONATE SODIUM 56 50 31 22
CITALOPRAM HBR 55 37 33 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 31 34 19
AMITRIPTYLINE HCL 53 33 R 35 69
FUROSEMIDE 51 41 36 8
CLOTRIMAZOLE-BETAMETHASONE 50 32 37 147
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 22, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.